Lilly, Boehringer retrench in Germany on proposed health spending cuts
礼来和勃林格殷格翰因拟议削减医疗支出在德国收缩业务

Backlash is brewing against a sweeping overhaul of Germany’s health insurance system as Eli Lilly and Boehringer Ingelheim slash investment in the country.
德国医保体系的全面改革正酝酿强烈反弹，与此同时礼来和勃林格殷格翰正在削减在德投资。